Accepted for/Published in: JMIR Research Protocols
Date Submitted: May 10, 2021
Open Peer Review Period: May 10, 2021 - Jul 5, 2021
Date Accepted: Sep 10, 2021
Date Submitted to PubMed: Dec 3, 2021
(closed for review but you can still tweet)
Utility of a machine guided tool for assessing risk behavior associated with contracting HIV in three sites in South Africa: Protocol of an in-field evaluation
ABSTRACT
Background:
Mobile technology has helped to advance health programs, and studies have shown that an automated risk prediction model can successfully be used to identify patients that exhibit high probable risk of contracting human immunodeficiency virus (HIV). A machine guided tool is an algorithm that takes a set of subjective and objective answers of a simple questionnaire and computes an HIV risk assessment score.
Objective:
The primary objective of this study is to establish that machine learning can be used to develop machine guided tools and give us a deeper statistical understanding of the correlation between certain behavioral patterns and HIV.
Methods:
200 HIV negative adult individuals each across three South African study sites (two semi-rural and one urban) will be recruited. Study processes will include i) completing a series of questions (demographic, sexual behavior and history, personal, lifestyle, and symptoms) on an application system, unaided (assistance will only be provided upon user request); ii) two HIV tests (one per study visit) being performed by a nurse/counsellor according to South African national guidelines (to evaluate prediction accuracy of the tool) and, iii) communication of test results and completion of a user experience survey questionnaire. The output metrics for this study will be computed by using the participants risk assessment score as “predictions” and the test results as the “ground truth.” Analyses will be completed after visit 1 and then again after visit 2. All the risk assessment scores will be used to calculate the reliability of the machine guided tools.
Results:
This study is ongoing. Data collection has commenced and is expected to be completed in the second half of 2021. Ethical approval was received from the University of Witwatersrand Human Research Ethics Committee (ethics reference number 200312) on 20 August 2020.
Conclusions:
Machine guided risk assessment tools can provide a cost-effective alternative to large scale HIV screening and help in providing targeted counselling and testing to prevent the spread of HIV. Clinical Trial: The study was registered on the South African National Clinical Trial Registry (www.sanctr.gov.za) (DOH-27-042021-679). This study is funded by the Bill and Melinda Gates Foundation (OPP 1204282).
Citation
Request queued. Please wait while the file is being generated. It may take some time.
Copyright
© The authors. All rights reserved. This is a privileged document currently under peer-review/community review (or an accepted/rejected manuscript). Authors have provided JMIR Publications with an exclusive license to publish this preprint on it's website for review and ahead-of-print citation purposes only. While the final peer-reviewed paper may be licensed under a cc-by license on publication, at this stage authors and publisher expressively prohibit redistribution of this draft paper other than for review purposes.